ALGS vs PAYC · rev $3.6M vs P/E 33, rev $1.88B
Aligos Therapeutics Inc (ALGS) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
ALGS currently screens at market cap $44.1M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the ALGS and PAYC stock pages for the full models.
Not investment advice.